Refine by
Heart Pump Articles & Analysis
25 news found
Puzzle Medical Devices Inc. is delighted to announce its first-in-human results for the ModulHeart have been presented at the prestigious American Heart Association (AHA) meeting held November 5–7, 2022 at the McCormick Place Convention Center in Chicago, IL. Montreal-based Puzzle Medical Devices Inc. (PMD) developed a percutaneous heart ...
Montreal-based Puzzle Medical Devices Inc. (PMD) developed a percutaneous heart pump designed to support cardiac and renal function in patients with advanced heart failure (HF). ...
SQuEEZ is based on the ability in high resolution cardiac CT scans to track points on the endocardium as they move during the contraction of the heart to allow quantitative assessment of regional myocardial heart wall motion. The analysis of four dimensional SQuEEZ parameters has the potential to improve the ability to quantify accurately the regional myocardial ...
rst-in-human study to evaluate the performance of its ModulHeart percutaneous heart pump designed to reduce cardiac afterload and improve renal perfusion in patients with advanced heart failure (HF). ...
Fain to build upon the foundation of innovative technology established over recent years and accelerate the progression of product development leading to human clinical trials and commercialization of the company’s novel and proprietary heart pump. “Procyrion’s Board led an extensive CEO search and Eric was the Board’s clear choice given ...
” CardioWise’s SQuEEZ® is based on the ability in sequential high-resolution cardiac CT scans to track movement of individual points on the endocardium during the contraction of the heart. The analysis of SQuEEZ parameters has the potential to improve the ability to quantify accurately the ability of the heart to pump blood ...
CorWave, a French medtech company developing a nextgeneration heart pump, won the 2021 Healthtech Award in the Medtech category yesterday. ...
ByCorWave
Medicine and biomedical research In addition to medicine and biomedical research, JADBio can definitively perform survival analysis on several out-of-the-box and even what one may consider ‘weird’ cases, including: Health – Obviously, when analyzing health disciplines, we can actionably determine values such as the time to: death, device failure such as a ...
ByJADBio
CorWave, a French medtech developing a next-generation heart pump, is recruiting top talent from throughout the world to strengthen its team. ...
ByCorWave
The WiSE (Wireless Stimulation Endocardially) CRT System is designed to improve the heart’s pumping ability by synchronizing the left and right ventricles to distribute blood to the lungs and body more effectively. ...
CorWave, a French medical device company committed to the fight against heart failure, announced that it has successfully completed the first 90-day preclinical study to evaluate its left ventricular assist device (LVAD) operating synchronously with the native heart without the use of sensors. ...
ByCorWave
CorWave, a French medical device company committed to the fight against heart failure, unveiled an unprecedented study on the performance of its implantable heart pump at the 41st Annual Meeting of the International Society for Heart and Lung Transplantation (ISHLT). ...
ByCorWave
We look forward to building on this clinical experience.” About Heart Failure and Cardiac Resynchronization Therapy (CRT) Heart failure is a serious condition in which the heart is unable to pump enough blood to meet the body’s demands. A progressive, debilitating disease, heart failure often occurs ...
The idea of developing a minimally invasive heart pump arose during an entrepreneurship course at the École de technologie supérieure (ÉTS) being taken in 2018 by two mechanical engineering and robotics students, Jade Doucet-Martineau and François Trudeau, and during a discussion on the subject with a colleague, Dr. ...
CorWave, located in Clichy, Île-de-France, is developing an implantable heart pump (Left Ventricular Assist Device, LVAD) based on a breakthrough technology, the wave membrane pump. ...
ByCorWave
The patent filing also covers a simplified design for deploying and retrieving the impeller and aortic stent components of the circulatory assist pump. Second Heart Assist, Inc. Second Heart Assist, Inc. is focused on the development of two models of percutaneously placed aortic stent-based circulatory assist pumps primarily ...
NEWS PROVIDED BY Second Heart Assist, Inc. June 22nd, 2020 7:00am ET Salt Lake City, Utah, June 22nd, 2020 /PRDistribution/ — Second Heart Assist Inc., inventors of the first, true, aortic stent-based circulatory assist pump intended primarily for use in heart failure patients, announces the successful completion of a ...
Allan Will, former Chairman and CEO of EBR Systems, assumes the role of Executive Chairman of EBR Systems and remains actively involved with advancing the business. About Heart Failure and Cardiac Resynchronization Therapy (CRT) Heart failure is a serious condition in which the heart is unable to pump enough blood to meet the ...
CardioWise, Inc., is pleased to announce two significant patents protecting its heart function analysis software, Stretch Quantifier for Endocardial Engraved Zones (SQuEEZ). ...
It will enroll up to 350 randomized worldwide and is expected to complete enrollment in mid-2020. About Heart Failure and Cardiac Resynchronization Therapy (CRT) Heart failure is a serious condition in which the heart is unable to pump enough blood to meet the body's demands. A progressive, debilitating disease, ...